Illicit E-cigarette Sales Rise in UK, Concerns for Youth Heath

Regulations by 2FIRSTS.ai
Apr.17.2024
Illicit E-cigarette Sales Rise in UK, Concerns for Youth Heath
The trading standards team in Radnorshire County, UK, seized over 6000 illegal e-cigarettes in a crackdown operation.

According to a report from the Welsh newspaper "The National Youth Daily" on April 16th, the Trading Standards team of the local government in Reksem County, UK, confiscated over 6,000 illegal e-cigarettes in a crackdown operation in 2023.

 

According to data released by the Rexham Commission under the Freedom of Information Act, a total of 6,339 illegal e-cigarettes were discovered in the county's municipalities in 2023. This marks a 411% increase from the 1,240 e-cigarettes confiscated in 2022, with no previous records of such incidents in the preceding three years.

 

Illegal e-cigarette products have now become the primary item seized in the region. In comparison, only 1,516 packs of illegal cigarettes were seized last year, with the recent 2021 figures skyrocketing to as high as 7,834 packs.

 

A senior official from the local government has stated that they are specifically targeting illegal e-cigarettes due to concerns about their impact on children's health. This is particularly concerning as some illegal e-cigarette products have been found to contain nicotine levels far above what is permitted for sale on the market.

 

Roger Mapleson, trade standards officer at Reckham, stated, "Locally, market regulators have been monitoring the supply of illegal disposable e-cigarettes. These products have been gaining popularity over the past few years, attracting a significant number of non-smokers, especially children.

 

Although e-cigarette products are very effective aids in smoking cessation, a simple recommendation for non-smokers (both children and adults) is, if you do not smoke, do not use e-cigarettes. Disposable e-cigarette products are very popular, and illegal versions are stronger than what the law allows (containing more than 20mg of nicotine per milliliter of e-liquid), for example, exceeding the allowed size (more than 2ml of e-liquid), and versions without labels.

 

He also added, "Illegal e-cigarettes are entering our country through smuggling, completely unregulated, meaning that the content of these products is not controlled at all. Those selling illegal e-cigarettes are unlikely to restrict sales to those over 18 years old, and may sell them to children. Therefore, from a market supervision perspective, monitoring these products is of utmost importance."

 

Despite increased focus on cracking down on the illegal sale of e-cigarettes in recent years, the city council stated that illegal tobacco remains their top priority. Still, over 5,000 people nationwide die prematurely each year due to smoking-related causes.

 

Mr. Mapleson urges people to remain vigilant about the possibility of purchasing illegal products when it comes to e-cigarettes.

 

He said: "As a very rough guide, illegal e-cigarettes can be identified by looking at the number of puffs the product claims to offer. Anything over 600 puffs is suspicious, as illegal e-cigarettes often claim to provide several thousand puffs. In addition, you can check the nicotine strength indicated on the packaging. 20ml/mg is the maximum, usually considered as two percent. Anything higher is likely illegal. E-cigarettes sold on social media, workplaces, or other informal markets such as flea markets may also be illegal. E-cigarettes sold in mainstream high street stores and supermarkets are highly unlikely to be illegal products."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25